Author

Miheer Pujara

Institutions: University of Colorado Hospital, University of Colorado Anschutz, University of Colorado Denver

Observed institutions: University of Colorado Hospital, University of Colorado Anschutz, University of Colorado Denver

OpenAlex ID: A5037204639

Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non–Small-Cell Lung Cancer

2019 · Tejas Patil, Rao Mushtaq, et al. · Clinical Lung Cancer · 39

Clinicopathologic profile and treatment outcomes of non-sensitizing EGFR and HER2 (ERBB2) activating mutations in NSCLC: Results from a single-center retrospective study.

2019 · Tejas Patil, Rao Rashid Mushtaq, et al. · Journal of Clinical Oncology

Works count: 2

Citation count: 39

H-index: 1

I10-index: 1